A Phase I Trial of Berberine in Chinese with Ulcerative Colitis
Li Xu(Wannan Medical College), Kaichun Wu(Xijing Hospital), Guang‐Yu Yang(Southwest Forestry University), Sijung Hu(Xijing Hospital), Asad Umar(Center for Cancer Research), Aidong Wen(Xijing Hospital), Luz M. Rodriguez(Walter Reed National Military Medical Center), Kelly A. Benante(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Raymond C. Bergan(University of Nebraska Medical Center), Ellen Richmond(Georgetown University), Seema A. Khan(Northwestern University), Yujie Zhang(Xijing Hospital), Jie Liu(Guangdong 999 Brain Hospital), Yueyun Ma(Air Force General Hospital PLA), Yan Pan(Xijing Hospital), Ying Song(Fifth Tianjin Central Hospital), Borko Jovanovic(Northwestern University), Xianmin Xue(Xijing Hospital), Zeng-Shan Li(Xijing Hospital), Mary Beth Tull(Robert H. Lurie Comprehensive Cancer Center of Northwestern University), Yanyan Jia(Xijing Hospital), Ying Cao(Xijing Hospital)
Cited by 73
Related Papers
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991
Screening for gastric cancer in Asia: current evidence and practice
|The Lancet Oncology|2008|830
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants
|bioRxiv (Cold Spring Harbor Laboratory)|2021|480
Estimates of benefits and harms of prophylactic use of aspirin in the general population
|Annals of Oncology|2014|388